ABBV · AbbVie, Inc.
227.80
EURUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Euro402.25B
PE
93.00
EV/EBITDA
15.5
DIV Yield
3%
Payout Ratio
200%
MQV Rating
5Very Weak
As at 21/08/2026 12:00:00 AM
Price Chart
Description
- All-Companies
Key Fundamentals
EPS 3 yr Growth
-66.90%
EBITDA Margin
47.50%
Operating Cashflow
€16,862m
Free Cash Flow Return
30.60%
ROIC
6.70%
Interest Coverage
9.50
Quick Ratio
0.60
Performance
52 weeks range
Low 172.9 - 234.7
Trade Value (12mth)
US$275.00
1 week
2.26%
1 month
21.37%
YTD
19.45%
1 year
139.05%
All time high
234.70
Additional Data
Shares Outstanding (Fully Diluted)
1,771m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
15-Jul-26
Next Dividend Pay Date
14-Aug-26
Reporting Currency
EUR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
Key Stakeholders
| Name | Title |
| Richard A. Gonzalez | Individual |
| Blue Sparrow LLC (Delaware) | Private Company |
| Azita Saleki-Gerhardt | Individual |
| Robert A. Michael | Individual |
| Employees Provident Fund | Pension Fund |
